XTALPI's stock plummeted 6.45% during intraday trading on Friday, extending a recent downward trend.
The sharp decline is attributed to significant profit-taking by investors following the company's recent strong annual earnings report, which showed a remarkable turnaround to profitability. Additionally, short selling activity has intensified, with recent short-sale volume accounting for a substantial portion of total turnover, putting further downward pressure on the stock price.
The broader Life Sciences Tools and Services sector also traded lower during the session, contributing to the negative sentiment.